Search for content, post, videos

Qlucore approved for listing on Nasdaq First North Growth Market 

Qlucore has received approval of the application for listing of Qlucore shares on the Nasdaq First North Growth Market.

The first day of trading of the shares was 5th November 2021. Trading will be done with the ticker QCORE.

“This paves the way for a new phase in Qlucore’s development. With the funding from the rights issue in conjunction with this listing Qlucore now has the resources to launch its software globally and create conditions for better cancer care, with fast and precise large data set analysis,” says Pia Gideon, Chairman of the Board at Qlucore.

Qlucore has, as earlier communicated, concluded a rights issue to public and professional investors, both in Sweden and internationally, for a total of approximately 9.1 million EURO. The rights issue was fully subscribed. At the time of the rights issue it was also communicated that Qlucore had the intention to list shares on Nasdaq First North Growth Market. Qlucore has today received this approval.

Photo: iStock